XPO7 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.74169575931182E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.93489999969587E-07 |
Normal-vs-Stage2 |
8.376800E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
6.990000E-04 |
Stage1-vs-Stage2 |
1.558800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.877400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
3.589200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.95660163018852E-11 |
Normal-vs-AfricanAmerican |
2.179800E-01 |
Normal-vs-Asian |
1.036620E-01 |
Caucasian-vs-AfricanAmerican |
8.935900E-02 |
Caucasian-vs-Asian |
2.591600E-01 |
AfricanAmerican-vs-Asian |
7.002600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.31120000002038E-06 |
Normal-vs-Female |
2.18169999954831E-07 |
Male-vs-Female |
4.098200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.044100E-03 |
Normal-vs-Extreme_Weight |
1.79249999998632E-06 |
Normal-vs-Obese |
1.062930E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.383200E-01 |
Normal_Weight-vs-Obese |
2.842600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.493050E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.697160E-01 |
Normal-vs-Age(41-60Yrs) |
2.038100E-04 |
Normal-vs-Age(61-80Yrs) |
1.01789999762403E-08 |
Normal-vs-Age(81-100Yrs) |
3.180400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.089820E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.539570E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.511780E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.926000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.394200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.548200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.805560E-01 |
Normal-vs-Grade 3 |
1.742450E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.957600E-01 |
Grade 2-vs-Grade 4 |
1.805560E-01 |
Grade 3-vs-Grade 4 |
1.742450E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.09460000455408E-08 |
Normal-vs-N1 |
2.324400E-03 |
N0-vs-N1 |
6.539400E-01 |
|
|